Then all they'd have to do is take their version of iPPS through the same path as PAR have taken Zilosul, and prove over years and years of clinical evidence that it has the same safety and efficacy profile, then go through the registration with the FDA to have their iPPS approved as the second Drug Master File (after Zilosul) and once they've spent a decade a tens of millions of dollars doing that - they can infringe PAR's patents in all of the major markets by selling it as relief for OA/BMEL. Not sure how i'll sleep tonight.
- Forums
- ASX - By Stock
- PAR
- Don't call me...
Don't call me..., page-6
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
28.5¢ |
Change
-0.005(1.72%) |
Mkt cap ! $99.69M |
Open | High | Low | Value | Volume |
29.0¢ | 29.0¢ | 28.5¢ | $34.79K | 121.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 70181 | 28.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 0.295 |
2 | 84482 | 0.290 |
2 | 77982 | 0.285 |
5 | 71970 | 0.280 |
2 | 41363 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.260 | 79 | 1 |
0.285 | 25000 | 1 |
0.290 | 6930 | 1 |
0.300 | 2640 | 1 |
0.305 | 50000 | 1 |
Last trade - 14.42pm 24/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
Previous Video
Next Video
SPONSORED BY The Market Online